Financing resistance | Why new investors are urgently needed and where they come from

View Recordings and Slides here »

Regulatory perspective | Current status and the post-COVID outlook for antibiotic clinical trials & approvals

View Recordings and Slides here »

Global markets | Why we need to think global to tackle AMR

View Recordings and Slides here »

Diagnostics | Novel solutions to solve the reimbursement challenge

View Recordings and Slides here »

AMR pull incentives | Will COVID-19 speed up or slow down implementation?

View Recordings and Slides here »

Business models in AMR | How to develop strategic decisions in a challenging and global AMR market

View Recordings and Slides here »

Business models | The AMR company of the future – Which route to success

View Recordings and Slides here »

Closing session The future of AMR: How a new post-COVID-19 policy roadmap could look like

View Recordings and Slides here »